SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Senomys(SNMX)- A Taste for Success!!!
SNMX 1.4900.0%Nov 5 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: A.J. Mullen4/18/2007 12:37:11 PM
   of 192
 
Senomyx CEO Exercises Options
Wednesday April 18, 10:01 am ET

Senomyx Chief Executive Kent Snyder Sells 12,000 Shares

NEW YORK (AP) -- The chief executive and president of flavor research company Senomyx Inc. exercised options for 2,003 shares and sold 12,000 shares of common stock under a prearranged trading plan, according to a Securities and Exchange Commission filing.

In a Form 4 filed with the SEC Tuesday, Kent Snyder reported he exercised the shares Monday for 74 cents apiece and sold 12,000 shares the same day for $13.08 apiece.

The stock sale was conducted under a prearranged 10b5-1 trading plan which allows a company insider to set up a program in advance for such transactions and proceed with them even if he or she comes into possession of material non-public information.

Insiders file Form 4s with the SEC to report transactions in their companies' shares. Open market purchases and sales must be reported within two business days of the transaction.

Senomyx is based in La Jolla, Calif.

(AP)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext